Summary
Elevance Health, Inc. (formerly Anthem, Inc.) filed an 8-K on June 13, 2018, primarily to disclose financial guidance updates in connection with investor meetings. The company reaffirmed its net income guidance for the full year 2018, expecting it to be greater than $14.12 per share. This guidance includes approximately $1.18 per share in net negative adjustment items. Excluding these adjustments, Elevance Health continues to project adjusted net income to be greater than $15.30 per share for the full year 2018. This guidance is based on information previously reported in the company's first quarter 2018 earnings release and does not anticipate further adjustment items beyond those already disclosed. Investors should note that this information is furnished under Regulation FD and is not considered "filed" for purposes of Section 18 of the Exchange Act.
Key Highlights
- 1Reaffirmed 2018 full-year net income guidance: greater than $14.12 per share.
- 2Full-year 2018 adjusted net income guidance: greater than $15.30 per share.
- 3Net negative adjustment items are expected to be approximately $1.18 per share for full-year 2018.
- 4Guidance does not include adjustment items beyond those reported in Q1 2018 earnings.
- 5The disclosure is made in connection with investor meetings occurring between June 13, 2018, and June 29, 2018.
- 6Information furnished under Item 7.01 (Regulation FD Disclosure) is not deemed "filed" for Section 18 purposes.
- 7The report includes standard forward-looking statement disclaimers outlining various business risks and uncertainties.